Xtant Medical Holdings (XTNT) Change in Accured Expenses (2010 - 2025)
Xtant Medical Holdings' (XTNT) quarterly Change in Accured Expenses came in at $958000.0 in Q3 2025, up 333.48% year-on-year from $221000.0 in Q3 2024, and up 4065.22% on a QoQ basis from $23000.0 in Q2 2025.
Xtant Medical Holdings (XTNT) Change in Accured Expenses (2010 - 2025) Analysis & Trends
Xtant Medical Holdings (XTNT) has 16 years of Change in Accured Expenses data on file, last reported at $958000.0 in Q3 2025.
- On a quarterly basis, Change in Accured Expenses rose 333.48% year-over-year to $958000.0 in Q3 2025; TTM through Sep 2025 was $2.6 million, a 724.76% increase from a year earlier, with the FY2024 full-year figure at -$2.9 million, down 176.95% from the prior year.
- Change in Accured Expenses for Q3 2025 stood at $958000.0, up from $23000.0 in the prior quarter.
- Over the last five years, Change in Accured Expenses for XTNT reached as high as $2.7 million in Q1 2025 and fell as low as -$1.6 million in Q3 2021.
- Historically, Change in Accured Expenses has averaged $243526.3 across 5 years, with a median of $221000.0 in 2024.
- Across the five-year window, Change in Accured Expenses soared 10636.36% in 2021 and plunged 788.78% in 2024, its largest moves.
- Year by year, Change in Accured Expenses stood at $270000.0 in 2021, then jumped by 75.93% to $475000.0 in 2022, then surged by 198.74% to $1.4 million in 2023, then plunged by 175.55% to -$1.1 million in 2024, then jumped by 189.37% to $958000.0 in 2025.
- Per Business Quant data, the three most recent Change in Accured Expenses figures were $958000.0 in Q3 2025, $23000.0 in Q2 2025, and $2.7 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.75 Bn | 176.46 Bn | 6.27 Bn | - |
| 2 | Stryker | 129.05 Bn | 126.17 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 108.57 Bn | 99.35 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 68.61 Bn | 67.16 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 48.41 Bn | 44.74 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn | 145.10 Mn |
| 7 | GE HealthCare Technologies | 28.12 Bn | 25.83 Bn | 1.98 Bn | -250.00 Mn |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 24.26 Bn | 21.14 Bn | 2.07 Bn | 21.07 Mn |
| 10 | Xtant Medical Holdings | 61.00 Mn | 43.68 Mn | 17.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 958,000.00 |
| Sep 30, 2025 | 958,000.00 |
| Jun 30, 2025 | 23,000.00 |
| Jun 30, 2025 | 23,000.00 |
| Mar 31, 2025 | 2.74 Mn |
| Mar 31, 2025 | 2.74 Mn |
| Dec 31, 2024 | -1.07 Mn |
| Dec 31, 2024 | -1.07 Mn |
| Sep 30, 2024 | 221,000.00 |
| Sep 30, 2024 | 221,000.00 |
| Jun 30, 2024 | -1.39 Mn |
| Jun 30, 2024 | -1.39 Mn |
| Mar 31, 2024 | -675,000.00 |
| Mar 31, 2024 | -675,000.00 |
| Dec 31, 2023 | 1.42 Mn |
| Dec 31, 2023 | 1.42 Mn |
| Sep 30, 2023 | 1.61 Mn |
| Sep 30, 2023 | 1.61 Mn |
| Jun 30, 2023 | 660,000.00 |
| Jun 30, 2023 | 660,000.00 |